Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 813,914 | 449,371 | -72,003 | 72,097 | 52,271 |
| Depreciation Amortization | 35,777 | 24,408 | 20,859 | 14,428 | 14,691 |
| Income taxes - deferred | -53,239 | 151,568 | -250,061 | N/A | N/A |
| Accounts receivable | 13,753 | -118,843 | -92,207 | -40,628 | -25,482 |
| Accounts payable and accrued liabilities | 23,356 | 11,903 | 6,144 | 5,232 | 8,454 |
| Other Working Capital | -253,407 | -126,304 | 391,386 | -31,994 | -30,822 |
| Other Operating Activity | 125,488 | 115,861 | 230,489 | 55,274 | -146,091 |
| Operating Cash Flow | $705,642 | $507,964 | $234,607 | $74,409 | $-126,979 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -634,527 | -436,048 | -190,229 | 113,419 | -97,191 |
| PPE Investments | -47,951 | -51,366 | -161,609 | -17,597 | 103,669 |
| Net Acquisitions | N/A | N/A | -375,507 | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 14,300 |
| Other Investing Activity | 0 | 0 | 0 | -50,000 | 0 |
| Investing Cash Flow | $-682,478 | $-487,414 | $-727,345 | $45,822 | $20,778 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 298,816 | N/A | N/A | 336,637 | N/A |
| Debt Repayment | -203 | -137 | -1,715 | -1,414 | -2,761 |
| Common Stock Issued | 143,283 | 78,796 | 83,806 | 51,386 | 36,311 |
| Financing Cash Flow | $441,896 | $78,659 | $82,091 | $386,609 | $33,550 |
| Exchange Rate Effect | -38,056 | -13,019 | -11,565 | -13,399 | -1,151 |
| Beginning Cash Position | 280,909 | 194,719 | 616,931 | 123,490 | 197,292 |
| End Cash Position | 707,913 | 280,909 | 194,719 | 616,931 | 123,490 |
| Net Cash Flow | $427,004 | $86,190 | $-422,212 | $493,441 | $-73,802 |
| Free Cash Flow | |||||
| Operating Cash Flow | 705,642 | 507,964 | 234,607 | 74,409 | -126,979 |
| Capital Expenditure | -47,951 | -51,366 | -161,609 | -17,597 | -26,331 |
| Free Cash Flow | 657,691 | 456,598 | 72,998 | 56,812 | -153,310 |